IndraLab

Statements

CYLD activates Carcinogenesis. 2 / 2
| 2
reach
"CYLD has also been shown to deubiquitinate (and inactivate) the coactivator BCL‐3 (117), which switches the transcriptional properties of NF‐κB from repressive to activating, and is known to strongly promote cell proliferation and oncogenesis (118, 119)."
20073038
reach
"CYLD has also been shown to deubiquitinate (and inactivate) the coactivator BCL-3 (117) , which switches the transcriptional properties of NF-jB from repressive to activating, and is known to strongly promote cell proliferation and oncogenesis (118, 119) ."
20073038